publication date: Dec. 8, 2017

Building a “hybrid” center by the Beltway, Trump pursues vision of a new national research network

By Paul Goldberg

As he goes about the task of building a cancer center, Donald “Skip” Trump has to align the money, the real estate, the recruitment—all the customary components of an institution.

Sure, all of this is more complex because Trump is building the Inova Schar Cancer Institute in hyper-competitive and wealthy Northern Virginia, literally by the outer loop of the Beltway.

But there is also something new he has to deal with: something loosely called “the networks.”

Backed by a $400 million war chest, Trump, a veteran—and one of the visionaries—of academic oncology, is pursuing an academic affiliation with the University of Virginia, but is also seeking to construct a separate nationwide network of high-quality and independent cancer centers.

These centers, collectively known as “hybrids,” combine characteristics of academic and community oncology, focusing heavily on clinical trials. This wave of mergers and hybridizations comes at a time when ever-growing reliance on information technology and ever-narrowing specialization of treatments are causing community care to take on the characteristics of academic centers.

In previous stories in this three-part series, The Cancer Letter focused on:

Inova retrofitting the former Mobil headquarters into a cancer center … Continue reading Building a “hybrid” center by the Beltway, Trump pursues vision of a new national research network

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.